CIK 0000907654
- Non-accelerated filer
- Smaller reporting company
Oruka Therapeutics, Inc.
Sign in to watch- Ticker
- ORKA
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 363855489
- Phone
- +1 650-606-7910
- Business address
- 855 OAK GROVE AVE., SUITE 100, MENLO PARK, CA, 94025
- Former names
- ARCA biopharma, Inc., NUVELO INC, HYSEQ INC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $21,431,111
- in 18 filings, $21.0M under 10b5-1 plans
Net −$21,431,111. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
- Klein Lawrence Otto −$11.6M Chief Executive Officer sold 12% of stake
- Agarwal Arjun −$2.8M Senior Vice President, Finance sold 68% of stake
- Quinlan Paul T −$2.6M General Counsel sold 49% of stake
- Goncalves Joana −$2.0M Chief Medical Officer sold 41% of stake
- BALL KRISTINE M −$1.9M Director sold 100% of stake
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2015-01-16 | mccormack riley 10% owner | Sale | −100,000 | $0.75 | $75K | 2,100,000 |
| 2015-01-15 | mccormack riley 10% owner | Sale | −125,000 | $0.75 | $94K | 2,200,000 |
| 2015-01-14 | mccormack riley 10% owner | Sale | −125,000 | $0.79 | $99K | 2,325,000 |
| 2015-01-07 | mccormack riley 10% owner | Sale | −200,000 | $0.87 | $174K | 2,450,000 |
| 2015-01-06 | mccormack riley 10% owner | Sale | −200,000 | $0.92 | $184K | 2,650,000 |
| 2015-01-05 | mccormack riley 10% owner | Sale | −150,000 | $0.97 | $146K | 2,850,000 |
| 2014-09-18 | Wheeler Patrick M Chief Financial Officer | Sale | −8,246 | $1.31 | $11K | 101,510 |
| 2014-09-18 | BRISTOW MICHAEL R President and CEO | Sale | −13,853 | $1.30 | $18K | 292,625 |
| 2014-02-27 | Wheeler Patrick M Chief Financial Officer | Grant or award | +34,200 | $1.95 | $67K | 109,756 |
| 2014-02-27 | Wheeler Patrick M Chief Financial Officer | Grant or award · Stock Option (right to buy) | +20,500 | 20,500 | ||
| 2014-02-27 | Ozeroff Christopher David S.V.P., General Counsel | Grant or award | +34,200 | $1.95 | $67K | 126,737 |
| 2014-02-27 | Ozeroff Christopher David S.V.P., General Counsel | Grant or award · Stock Option (right to buy) | +10,500 | 10,500 | ||
| 2014-02-27 | BRISTOW MICHAEL R President and CEO | Grant or award | +56,700 | $1.95 | $111K | 306,478 |
| 2014-02-27 | BRISTOW MICHAEL R President and CEO | Grant or award · Stock Option (right to buy) | +51,500 | 51,500 | ||
| 2014-02-11 | Woosley Raymond L. Director | Grant or award · Stock Option (right to buy) | +8,000 | 8,000 | ||
| 2014-02-11 | CONWAY ROBERT E Director | Grant or award · Stock Option (right to buy) | +8,000 | 8,000 | ||
| 2014-02-11 | Grais Linda S Director | Grant or award · Stock Option (right to buy) | +8,000 | 8,000 | ||
| 2014-02-04 | mccormack riley 10% owner | Purchase | +1,000,000 | $1.70 | $1.7M | 3,000,000 |
| 2014-02-04 | mccormack riley 10% owner | Purchase · Warrant to purchase common stock | +250,000 | 250,000 | ||
| 2013-09-17 | ZABRISKIE JOHN L Director | Grant or award · Stock Option (right to buy) | +16,000 | 16,000 |
Page 25 of 41 · 802 trades